🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 8 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/11/2018 14,36 14,66 14,02 14,49 +1,90% 4,46% 1.460.800
01/11/2018 12,76 14,23 12,72 14,22 +11,79% 11,83% 2.676.900
31/10/2018 12,73 13,11 12,51 12,72 +2,09% 4,71% 1.613.800
30/10/2018 12,10 12,57 12,05 12,46 +1,71% 4,28% 1.459.900
29/10/2018 12,81 12,99 11,89 12,25 -3,24% 8,59% 2.400.400
26/10/2018 12,33 12,89 12,04 12,66 +0,72% 6,89% 1.319.600
25/10/2018 12,01 12,84 12,00 12,57 +4,92% 6,99% 1.806.000
24/10/2018 12,91 13,00 11,98 11,98 -7,56% 7,88% 2.195.700
23/10/2018 12,55 13,29 12,29 12,96 -0,15% 7,97% 1.447.800
22/10/2018 13,08 13,16 12,25 12,98 -0,54% 6,96% 1.438.000
19/10/2018 13,53 13,70 12,81 13,05 -2,25% 6,58% 2.191.100
18/10/2018 13,51 13,60 12,96 13,35 -1,04% 4,73% 1.526.000
17/10/2018 13,53 14,23 13,30 13,49 -2,74% 6,87% 2.067.200
16/10/2018 13,04 14,00 13,00 13,87 +5,48% 7,67% 2.317.400
15/10/2018 12,91 13,36 12,75 13,15 +0,31% 4,70% 1.885.000
12/10/2018 13,15 13,94 12,51 13,11 +1,79% 10,87% 2.409.900
11/10/2018 12,45 13,44 12,31 12,88 +1,90% 9,08% 3.261.900
10/10/2018 13,61 13,79 12,52 12,64 -8,14% 9,35% 4.333.900
09/10/2018 13,50 14,32 13,15 13,76 +0,07% 8,68% 2.835.100
08/10/2018 14,71 14,87 12,85 13,75 -6,72% 13,73% 5.624.800
05/10/2018 15,69 15,88 14,22 14,74 -3,85% 10,58% 6.033.800
04/10/2018 19,85 20,31 14,75 15,33 -17,40% 28,01% 19.095.200
03/10/2018 19,70 19,94 17,84 18,56 -5,79% 10,66% 2.057.700
02/10/2018 19,42 19,74 18,76 19,70 +2,55% 5,05% 2.293.200
01/10/2018 19,17 19,46 18,82 19,21 +0,21% 3,34% 1.270.600
28/09/2018 19,00 19,43 19,00 19,17 +0,89% 2,26% 1.217.900
27/09/2018 19,03 19,44 18,78 19,00 -0,58% 3,48% 732.100
26/09/2018 19,37 19,54 19,04 19,11 -1,34% 2,58% 741.200
25/09/2018 18,70 19,45 18,53 19,37 +3,58% 4,92% 1.249.700
24/09/2018 17,77 18,79 17,43 18,70 +5,23% 7,65% 1.322.000